Stock Code: 000661
Stock Abbreviation: Changchun High-Tech
Announcement No.: 2026-054
Changchun High-Tech Industries (Group) Co., Ltd.
Announcement on Approval of GenSci164 Injection Domestic Production Drug Registration Clinical Trial Application by Subsidiary
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Recently, Changchun High-Tech Industries (Group) Co., Ltd. (hereinafter referred to as the "Company") and its subsidiary, Jilin Changchun GeneScience Pharmaceutical Co., Ltd. (hereinafter referred to as "GeneScience Pharmaceutical"), received a "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration. The clinical trial application for the domestic production drug registration of GeneScience Pharmaceutical's GenSci164 Injection has been approved. The relevant matters are hereby announced as follows:
I. Basic Information of the Drug